Health Advance Inc. (@HADVPresident) header
Health Advance Inc. (@HADVPresident) profile picture

HADV President, Larry McLachlin, experienced business executive. In this phase of his career, Larry has shifted focus to high energy emergent enterprise. $HADV

Joined March 2021
Health Advance and JASTLabs. News out from JASTLabs. $HADV Good development for HADV. accessnewswire.com/newsroom/…
2
1
3
7
1,217
Health Advance and JASTLabs. Tomorrow, JASTLabs will be publicly announcing where it stands on its patent progress. That is the key commercial validator of the JASTLabs valuation, that JASTLabs needs for their investment funding. Therefore, if JASTLabs announces positive forward movement of their portfolio, that would be good for HADV. It would demonstrate the solid foundation of HADV's own financial planning strategy.
Replying to @HADVPresident
Thank You for the update!
1
2
4
855
Hello LSTP - Mr. Canouse was willing to support the company during preparations for the JASTLabs transaction, which had been long term. He looks forward to retirement of his position. When OTCID is restored in the next few days, we will be providing further updates about JASTLabs.
@HADVPresident Canouse is a predatory loan shark that destroys cap tables. There is a reason why the market dislikes him. Do you have JAST support now so no need of otc loan sharks?
1
3
4
2,659
Health Advance OTCID reinstatement scheduled for this week. Then, OTCIQ information platform will be used for further in-depth updates.
3
10
1,270
$HADV Health Advance Shareholder Update Re Financing: otcmarkets.com/stock/HADV/ne…
4
1
1
6
2,051
Health Advance: More information about the non-dilutional incoming investment process for Health Advance is described in the HADV Annual Report, now filed for Fiscal Year ending March 31st: static.otcmarkets.com/filing… $HADV
3
1
5
1,029
HADV Non-Dilutional Financing: JASTLabs advancing in its Reg D and Reg A+ private and public offering - A percentage to be invested on non-loan basis into Health Advance. Target JASTLabs raise is $75 Million. No HADV commons share dilution needed. LINK: manhattanstreetcapital.com/j…
2
6
261
HADV relationship to JASTLabs.com is a remarkable "behind-the-scenes" breakthrough. Few people have yet discovered the funding finesse that this deal represents for Health Advance's future - without associated common share dilution. LINK: manhattanstreetcapital.com/j…
🤖 Made with AI
1
206
Additional series of JASTLabs investor ads appearing in social media. Capital raised in JASTLabs will be applied in part toward capital infusion at Health Advance on a basis that is not repayable and not dilutional to HADV common stock. $HADV LINK: manhattanstreetcapital.com/j…
3
1
3
646
$HADV Responses are coming into JASTLabs offering. Health Advance will receive capital investment as part of the JASTLabs business plan. This capital is not debt and does not dilute HADV common shares. JASTLabs.com
1
1
1
3
582
$HADV Offering Page for JASTLabs going live. A portion of these proceeds will be allocated to HADV for growth. LINK: manhattanstreetcapital.com/j…
1
216
$HADV Investment Funding Process Underway. JASTLabs advertising under SEC Reg D (Rule 506C) has started. Initial candidates are coming forward. JASTLabs will be using a portion of proceeds in 2026 and 2027 for capital investment into HADV with no common stock dilution arising therefrom.
2
5
396
Health Advance Shareholder Question Answered: Yes, a further update as soon as the JASTLabs Corporation Reg D (Rule 506C) social media advertising begins. It will be any day now.
Replying to @HADVPresident
Hi, @HADVPresident Is there any estimated time for next update / pr?
2
1
4
1,072
Health Advance shareholders - Pleased to report that the JASTLabs Regulation D Rule 506C offering advertising starting in social media next week. HADV will be receiving a capital investment from portion of proceeds, without HADV common share dilution and not repayable. $HADV
4
4
6
4,986
Invitation @Resan75262906 If you genuinely believe that the arrangements with Mr. Canouse are so beneficial to him that they are exhorbitant, then you would presumably be interested in replacing him in such arrangements, and providing such financing yourself instead of Mr. Canouse, in his place If so, then I am sure that Mr. Canouse would be delighted for you to take over. Mr. Canouse's biggest problem is that firms who accept his investment loans are in difficult straights when they turn to him with promises of how well they will do in their business going forward. Then, reality sets in, and goals are not met. That means that the investment loans (which would have been at a normal commercial rate) are not retired on time and need to go into a conversion exercise, at least a couple of years later. If even half of the CEOs who turn to him at a time of need would come slightly close to realizing the fancy business plans that they originally presented to him, he would be thrilled. Instead, it's always a litany of excuses. Bottom Line: Without the intervention of investment lenders like Mr. Canouse, many shareholders would see their holdings go into reverse mergers due to terminal failure. In the case of HADV, the company now has a new financing path to implement in 2026. The Canouse investment gave the company time to create the new structure.
Replying to @HADVPresident
Hilarious, you are calling Canouse a friend? You are either completely ignorant or clueless.
3
317
Health Advance Inc. retweeted
Replying to @HADVPresident
Hilarious, you are calling Canouse a friend? You are either completely ignorant or clueless.
1
1
1
466
The past convertible note holder enabled HADV to remain in good standing with regulatory authorities, and keep things going. The person that you refer to has been a friend to the company and is very happy that the company will receive this non-dilutional support.
Replying to @HADVPresident
What about conversions and Canouse notes that guy is not good for the company as people know his game very well...anything on that Sir
4
5
398
Health Advance Shareholder Update - Material Development. Important step forward. LINK to PDF at OTC Markets News Desk: 5 Page Document: otcmarkets.com/news-otcapi/n… $HADV
2
1
1
7
853
Health Advance Shareholder Update: Important Positive Development On Page 3 of the September 7, 2025 "Shareholder Questions Answered News Release" is a description of the pharmaceutical product to which (OTCID:HADV) will have a financial relationship. (Link at the end of this post). That project is proceeding. The green light has been given Nov 13, 2025 by the process cost backer, and his attorney. Health Advance involvement in this project will culminate in a capital infusion to HADV that does not dilute HADV common shares. The infusion will be from the proceeds of that organization's capital raise. Details will be discussed more in the upcoming HADV Quarterly Report that will be filed on November 19th instead of today. The 5 day delay in the Q filing is so that HADV management can properly reflect this important development in an MD&A discussion of the positive implications for HADV's future, as a "Subsequent Event" addition to the reporting period. Reference Page 3 of the following document to be reminded of the context: Link: otcmarkets.com/news-otcapi/n… $HADV
2
5
435
$HADV *** IMPORTANT TIP WHEN READING SHAREHOLDER UPDATES *** When opening PDF news releases and shareholder updates via the link to OTC Markets, it is important to click on the icon in the upper right corner (shown below as box with arrow coming out) to activate all live links and provide easy scrolling between pages.
2
1
652